Anthony O. Estrada,Alan G. Olivero,Snahel Patel,Michael Siu,Joseph Lyssikatos
申请号：
US15852235
公开号：
US20180117044A1
申请日:
2017.12.22
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides for compounds of Formula I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R1, R2, R3, X1, X2, A and Cy variable in Formula all have the meaning as defined herein.
